Korea Disease Control and Prevention Agency (KDCA) Commissioner Lim Seung-kwan outlines measures to advance Korea's infectious disease crisis management system at the National Biobank of Korea in Cheongju, North Chungcheong Province, Wednesday. Yonhap
Korea is expanding its role in global infectious disease research, joining international clinical trial networks led by U.S. and Singaporean institutions in a move aimed at strengthening preparedness for future pandemics and other public health threats.
The National Institute of Infectious Diseases, under the Korea National Institute of Health affiliated with the Korea Disease Control and Prevention Agency (KDCA), said Thursday that it has established frameworks to support Korean medical institutions participating in multinational infectious disease clinical trials through partnerships with the U.S. National Institutes of Health (NIH) and the National University of Singapore.
The initiative is designed to give Korean hospitals a greater role in international studies targeting emerging infectious diseases and antimicrobial-resistant bacteria, while building long-term clinical research capacity.
The institute said it first joined the NIH-supported STRIVE network in 2023 and later established cooperation with the National University of Singapore's Asia Infectious Disease Clinical Trial Network in 2024.
